17 Paid Clinical Research Studies in Huntsville, Alabama

LEADERS FREE II: BioFreedom™ Pivotal Study

This study aims to confirm non-inferiority of the BioFreedom™ Drug Coated Stent to the Gazelle™ Bare Metal Stent arm of the Leaders Free study (NCT01623180) in high bleeding risk p

📍 Heart Center Research, LLC — Huntsville, Alabama

💵 In this study all patients will receive the BioFreedom™ Drug Coated Stent and one month of Dual Anti Platelet Therapy In

The Immediate and Long-term Effects of a Novel Marine-based Iron Supplement in Adult Females

The goal of this study is to identify how well a fish-based iron supplement is absorbed and to learn how many, if any, digestive related side effects are caused by ingesting the su

📍 Nutraceuticals Research Institute — Huntsville, Alabama

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

This study is a prospective, multi-center, pivotal trial to study the safety and efficacy of the WiSE-CRT System for Cardiac Re-synchronization Therapy.

📍 Heart Center Research — Huntsville, Alabama

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults

The main objective of Part A of this trial is to evaluate the safety and reactogenicity of mRNA-1189 in 18- to 30-year-old healthy adults, the main objective of Part B is to evalua

📍 Medical Affiliated Research Institute — Huntsville, Alabama

A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Marburg Virus Vaccine in Healthy Adults

A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored

📍 Optimal Research; LLC — Huntsville, Alabama

Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility

The aims of this protocol are: to collect and store diseased and normal tissue and body fluid samples from new and returning patients at St. Jude Children's Research Hospital (SJCR

📍 St. Jude Clinic at Huntsville Hospital for Women & Children — Huntsville, Alabama

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Generalized anxiety disorder (GAD) is usually treated with antidepressant therapy (ADT); however, sometimes ADTs alone are not enough to adequately treat GAD. The purpose of this s

📍 University of Alabama - Huntsville Regional Medical Campus /ID# 267818 — Huntsville, Alabama

💵 Participants will receive oral capsules of ABBV-932 or matching placebo in addition to their prescribed ADT for 6 weeks

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

The purpose of this study is to evaluate the safety and pharmacokinetics (PK) of AZD7760 when given as an intravenous infusion to healthy participants (Phase I) or participants wit

📍 Research Site — Huntsville, Alabama

Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+

This study evaluates the subjective effects of injection administration of NR on healthy adult populations.

📍 Nutraceuticals Research Institute — Huntsville, Alabama

Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study

Many individuals develop dementia, and dementia has multiple causes, yet we currently have limited treatment options. A critical observation of the effectiveness of the available d

📍 Smith Family Clinic for Genomic Medicine — Huntsville, Alabama

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to

📍 Rehabilitation & Neurological Services /ID# 229969 — Huntsville, Alabama

💵 For qualifying migraine attacks, participants will receive oral tablets of the double-blind study intervention.

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Migraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomi

📍 Rehabilitation and Neurological Services /ID# 270782 — Huntsville, Alabama

💵 Participants will receive oral tablets of atogepant or placebo once daily for 12 weeks and will be followed for 4 weeks.

Collection and Distribution of Biospecimens for Novel Research Uses

iSpecimen aims to create a clinical partner network of hospitals, laboratories, academic institutions, and other healthcare organizations ("institutions") capable of providing rese

📍 iSpecimen — Huntsville, Alabama

Effects of Ashwagandha Extract on Stress Levels

The purpose of this study is to evaluate the efficacy of two proprietary ashwagandha extracts on stress levels, with secondary outcomes of cognition, energy, and sleep, as compared

📍 Nutraceuticals Research Institute — Huntsville, Alabama

Evaluating Stairway Designs for Individuals With Vision Impairment

The goal of this study is to learn if contrast frequency on step tread-edges influences foot clearance measures, a marker of fall risk, in older adults with and without visual impa

📍 University of Alabama in Huntsville — Huntsville, Alabama

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United States. This study will assess h

📍 University of Alabama - Huntsville Regional Medical Campus /ID# 272951 — Huntsville, Alabama

💵 Participants will receive oral capsules of Icalcaprant or matching placebo once daily for 6 weeks, with a 4-week safety

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Colorectal cancer (CRC) is the third most common type of cancer diagnosed worldwide. The purpose of this study is to assess change in disease activity when telisotuzumab adizutecan

📍 Clearview Cancer Institute - Huntsville - Cci Drive /ID# 278621 — Huntsville, Alabama

💵 In arm 1 participants will receive telisotuzumab adizutecan alone.